| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/22/2002 | WO2002064097A2 Vegf-d expression in brain cancer |
| 08/22/2002 | WO2002064092A2 Method for evaluating therapeutic efficacy |
| 08/22/2002 | WO2002064086A2 Method for the separation of adsorbents from microbiological growth media |
| 08/22/2002 | WO2002064023A2 Fra-1 expression in brain cancer |
| 08/22/2002 | WO2002064015A2 Pin1 as a marker for prostate cancer |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002044361A3 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 08/22/2002 | WO2002043559A3 Methods and kits for diagnosis of schizophrenia |
| 08/22/2002 | WO2002042486A9 Methods for detection of a nucleic acid by sequential amplification |
| 08/22/2002 | WO2002040698A3 Analysis of soluble factor biological markers |
| 08/22/2002 | WO2002029411A3 Magnetic in situ dilution |
| 08/22/2002 | WO2002028999A3 Gene expression profiles in granulocytic cells |
| 08/22/2002 | WO2002026107A3 Model for neurodegenerative diseases involving amyloid accumulation |
| 08/22/2002 | WO2002024221A3 Notch receptor agonists and uses |
| 08/22/2002 | WO2002006509A3 Glucose-1-phosphate thymidylyltransferase and method for selecting inhibitors thereof |
| 08/22/2002 | WO2001081920A3 Comparative phenotype analysis for assessment of biologically active compounds |
| 08/22/2002 | WO2001081557A3 Human kinase proteins and polynucleotides encoding the same |
| 08/22/2002 | WO2001079239A3 Haplotypes of the ghrhr gene |
| 08/22/2002 | WO2001075143A3 Sigma binding region of rna polymerase and uses thereof |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001073119A3 Methods for genotyping by hybridization analysis |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2001070982A3 Brca-1 regulators and methods of use |
| 08/22/2002 | WO2001068900A3 Method for specifically detecting microorganisms by polymerase chain reaction |
| 08/22/2002 | WO2001042506A9 T1 receptor-like ligand ii and uses thereof |
| 08/22/2002 | WO2001040522A3 Short shared nucleotide sequences |
| 08/22/2002 | WO2001008720A3 Hypocretin and hypocretin receptors in regulation of sleep and related disorders |
| 08/22/2002 | WO2000026247A9 Ikaros isoforms and mutants |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | WO2000011195A9 C-myc is activated by beta-catenin and tcf-4 |
| 08/22/2002 | WO2000011186A9 Modified hcv peptide vaccines |
| 08/22/2002 | WO2000006771A9 Nucleic acid labeling compounds |
| 08/22/2002 | US20020116726 Muir-torre-like syndrome in Fhit deficient mice |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020115851 Ammonium sulfate for neutralization of inhibitory effects |
| 08/22/2002 | US20020115849 Plant promoter activated by fungal infection |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115841 Removing nucleotide sequence probe from sample mix; obtain sample nucleic acid, incubate with nucleic acid probe, remove probe from sample |
| 08/22/2002 | US20020115830 Detecting modulator of viral activity; for use in treatment of viral diseases |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115828 Nucleotide sequences for use in the detection of microorganismal infections |
| 08/22/2002 | US20020115631 Human bad polypeptides, encoding nucleic acids and methods of use |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115626 Comparing the expression of the nucleic acid encoding an antileuko-protease polypeptide of a cell population to the expression of a nucleic acid encoding the same peptide in an inflammation positive reference profile; enzyme inhibitors |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115607 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); diagnosis, drug screening, animal models |
| 08/22/2002 | US20020115606 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); modulating, in a cell, a protein complex between PN7740 and ligand Fe65 or PSD95 |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | US20020115591 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics |
| 08/22/2002 | US20020115559 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces |
| 08/22/2002 | US20020115308 Semiconductor device with porous interlayer insulating film |
| 08/22/2002 | US20020115225 Microdevices for high-throughput screening of biomolecules |
| 08/22/2002 | US20020115223 In vitro system for determining formation of abeta amyloid |
| 08/22/2002 | US20020115215 Adjusting chromatin in cells; obtain cells, incubate with fusion proteins, monitor activity of chromosomes |
| 08/22/2002 | US20020115210 Vectors and methods for the mutagenesis of mammalian genes |
| 08/22/2002 | US20020115207 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/22/2002 | US20020115191 KdtB |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/22/2002 | US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders |
| 08/22/2002 | US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 08/22/2002 | US20020115166 Peptide for use in the treatment of pancreatic defects |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115144 Nucleotide sequences coding protein for use in the diagnosis and treatment of intracellular vessicle defects |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115135 Synapse related glycoproteins |
| 08/22/2002 | US20020115131 Rapid readout sterilization indicator for liquid peracetic acid sterilization procedures |
| 08/22/2002 | US20020115128 Synthesis of chlorophenol red glucuronic acid |
| 08/22/2002 | US20020115127 MONITOR PROTEIN C ANTICOAGULATION; ACTIVATE COAGULATION CASCADE, TRIGGER COAGULATION, INCUBATE, MEASURE ACTIVITY OF EXOGENOUS SUBSTRATE, COMPARE TO CONTROL; Bioassay for qualitative and/or quantitative determination of functional activity of components of protein c anticoagulant pathway |
| 08/22/2002 | US20020115119 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020115116 Isolating preferential polypeptides from sample; obtain sample, express genes and generate fusion proteins, immobilize fusion protein, incubate with binding particle, recover bound particles |
| 08/22/2002 | US20020115115 Uses of mammalian genes and related reagents |
| 08/22/2002 | US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 08/22/2002 | US20020115108 Enzymes having high temperature polymerase activity and methods of use thereof |
| 08/22/2002 | US20020115103 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/22/2002 | US20020115101 Including large number of spots of sample solution arranged on base plate by supplying solution from dispenser onto plate, wherein solution is supplied a plurality of times to form one spot and solution is dried, thickened, solidified |
| 08/22/2002 | US20020115098 Detection of genetic agjustment in nucleotide sequences; obtain solid support, incubate with nucleotide sequence and probes, monitor signal from solid support |
| 08/22/2002 | US20020115097 Determining the number of thymidine-adenine repeats that correlates with the expression of the glucuronosyltransferase (UGT) gene |
| 08/22/2002 | US20020115095 Production method of micro-reactors gene chips |
| 08/22/2002 | US20020115094 Liver tumor marker sequences |
| 08/22/2002 | US20020115093 Combined polynucleotide sequences as discrete assay endpoints |
| 08/22/2002 | US20020115092 Label for use in nucleotide sequence analysis |
| 08/22/2002 | US20020115091 Compounds for use as tools in sequence analysis |
| 08/22/2002 | US20020115090 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 08/22/2002 | US20020115089 Simultaneous collection of DNA and non-nucleic analytes |
| 08/22/2002 | US20020115088 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 08/22/2002 | US20020115087 Detecting respiratory disorder; obtain tissue sample, determine nucleotide sequence, incubate with probes, determine genotype, evaluate for genetic disorders |
| 08/22/2002 | US20020115086 Diagnosing allergic dermatitis in humans; obtain cells, extract nucleotide sequence, incubate with probes, measure concentration of preferential interleukin, ampified concentrations of interleukins in skin indicates allergic |
| 08/22/2002 | US20020115085 Cancer gene determination and therapeutic screening using signature gene sets |
| 08/22/2002 | US20020115084 Detection of mycosphaerella using the polymerase chain reaction |
| 08/22/2002 | US20020115082 Methods and compositions for polynucleotide analysis using generic molecular beacons |
| 08/22/2002 | US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders |
| 08/22/2002 | US20020115080 Detection of mutations in genes by specific LNA primers |
| 08/22/2002 | US20020115079 Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
| 08/22/2002 | US20020115077 Detecting fungal cells in sample; obtain blood, extract nucleotide sequences, incubate with primers, detect fungal nucleotide sequences |